News

Recorded: 9 Sept 20254pm EAT / 3pm CEST (1h Leveraging PMX for Optimal Study designs in Resource-Limited Settings About the SpeakerFrancis Williams Ojara is a Post-doctoral pharmacometric modeler at the Infectious Diseases Institute and a lecturer of pharmacology at Gulu University. He holds a Doctorate in Natural Sciences (focusing on Pharmacometrics). His research covers modelling of pharmacokinetic-(and pharmacodynamic) data in oncology and infectious diseases, with current interests in understudied populations such as the pediatrics and pregnant mothers. He has strong interest in training and mentoring scholars into pharmacometrics and establishing potent global networks to support the growth of pharmacometrics in Uganda and Africa. About this seriesSharing knowledge, presenting advances and discussing best practices in pharmacometrics, featuring locally-relevant case studies in application of PBPK and pop-PK Who should attend:Anyone interested in learning how pharmacometrics helps to enable safe and effective use of medication

Recorded: 22 July 20254pm EAT / 3pm CEST (1h) Leveraging Pharmacometrics for Smarter TDM in Resource-Limited Settings About the SpeakerDr. Francine Johansson Azeredo is a Research Assistant Professor in the Department of Pharmaceutics at the University of Florida College of Pharmacy. Her work bridges translational pharmacokinetics/pharmacodynamics (PK/PD), infectious disease modeling, and precision medicine. Dr. Azeredo’s research focuses on model-informed drug development (MIDD), integrating preclinical and clinical data through advanced pharmacometrics approaches. Her projects address global health challenges such as malaria, hepatitis B, and antimicrobial resistance. She has served as PI or Co-I on several funded studies in both the U.S. and Brazil and is an editorial member of Frontiers in Pharmacology and the European Journal of Pharmaceutical Sciences. About this series Sharing knowledge, presenting advances and discussing best practices in pharmacometrics, featuring locally-relevant case studies in application of PBPK and pop-PK Who should attend: Anyone interested in learning how pharmacometrics helps to enable safe and effective use of medication

Recorded: 24 June 20254pm EAT / 3pm CEST (1h) Understanding ADME Using Physiologically Based Pharmacokinetic Modelling About the SpeakerDr. Ian Haworth is Vice Chair of the Department of Pharmacology and Pharmaceutical Sciences at the Mann USC School of Pharmacy and Pharmaceutical Sciences. He received his PhD in Physical Organic Chemistry from the University of Liverpool, UK, and then spent three years as a Postdoctoral Fellow at the University of Oxford, UK, before joining USC in 1992. Dr. Haworth has a major role in teaching of medicinal chemistry and biopharmaceutics in the PharmD, PhD and Masters programs at USC, and he has lectured and taught courses on this content worldwide. Dr. Haworth’s research work lies at the interface of chemistry, biochemistry, and computational research in pharmacodynamics and pharmacokinetics. This work involves development and utilization of algorithms for prediction of ligand-protein interactions, coupled with methodology for pharmacokinetic simulations. Dr. Haworth’s laboratory has published over 100 scientific articles on this work. Current projects include examining the relationship of affinity with solvation at drug- protein interfaces; exploration of parameters used in PBPK modeling; and use of molecular informatics and AI for prediction of molecular properties. About this series Sharing knowledge, presenting advances and discussing best practices in pharmacometrics, featuring locally-relevant case studies in application of PBPK and pop-PK Who should attend: Anyone interested in learning how pharmacometrics helps to enable safe and effective use of medication